HUMAW   $1.65  -6.25% Market Closed

Humacyte Inc
Total Cash 93.56M
totalCashPerShare 0.784
EBITDA -99.65M
Total Debt 18.93M
quickRatio 5.269
currentRatio 5.413
Total Revenue
debtToEquity
Revenue/Share
ROA -0.43605
ROE -8.50807
grossProfits
freeCashflow -49.98M
operatingCashflow -80.70M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue
forwardPE
floatShares 84.80M
sharesOutstanding
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders
heldPercentInstitutions
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue -0.237
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -139.66M
trailingEps -3.16%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 10
lastUpdated Sept. 16, 2024, 8:33 p.m.